financetom
Business
financetom
/
Business
/
Wesco International Insider Sold Shares Worth $1,046,855, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wesco International Insider Sold Shares Worth $1,046,855, According to a Recent SEC Filing
Sep 2, 2025 2:24 PM

05:03 PM EDT, 09/02/2025 (MT Newswires) -- Hemant Porwal, Executive Vice President, Supply Chain & Operations, on August 28, 2025, sold 4,656 shares in Wesco International ( WCC ) for $1,046,855. Following the Form 4 filing with the SEC, Porwal has control over a total of 19,141 common shares of the company, with 19,141 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/929008/000181636925000005/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Knightscope Gets Nasdaq Extension to Regain Compliance; Shares Jump
Knightscope Gets Nasdaq Extension to Regain Compliance; Shares Jump
Jun 5, 2024
10:58 AM EDT, 06/05/2024 (MT Newswires) -- Knightscope ( KSCP ) said Wednesday the Nasdaq has granted it an extension until Oct. 4 to implement a reverse stock split to help the company regain compliance with the bid price rule for continued listing. The company said the reverse stock split shall be undertaken on or before Sept. 20 after obtaining...
--Boeing's Starliner Lifts Off on First Crewed Mission
--Boeing's Starliner Lifts Off on First Crewed Mission
Jun 5, 2024
10:56 AM EDT, 06/05/2024 (MT Newswires) -- Price: 189.02, Change: +0.40, Percent Change: +0.21 ...
What's Going On With MindMed And Psychedelic Stocks?
What's Going On With MindMed And Psychedelic Stocks?
Jun 5, 2024
Mind Medicine (MindMed) Inc. ( MNMD ) shares are trading lower Wednesday after a Food and Drug Administration (FDA) panel rejected the approval of MDMA therapy for people with post-traumatic stress disorder (PTSD). The Details: MindMed and other psychedelic stocks, including ATAI Life Sciences N.V ( ATAI ) and COMPASS Pathways Plc ( CMPS ) , are down after an...
Atea Pharmaceuticals Shares Promising Data From Therapy Study For Hepatitis C Virus
Atea Pharmaceuticals Shares Promising Data From Therapy Study For Hepatitis C Virus
Jun 5, 2024
Atea Pharmaceuticals Inc ( AVIR ) announced Wednesday new data from the lead-in cohort (n=60) of the company’s ongoing Phase 2 combination study of bemnifosbuvir for hepatitis C virus (HCV). With an eight-week treatment duration in 60 patients, the Phase 2 data from the lead-in cohort of non-cirrhotic patients showed a 97% sustained virologic response rate at 12 weeks post-treatment...
Copyright 2023-2025 - www.financetom.com All Rights Reserved